These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7356037)

  • 1. Preservation of ischemic myocardium by pinane thromboxane A2.
    Schrör K; Smith EF; Bickerton M; Smith JB; Nicolaou KC; Magolda R; Lefer AM
    Am J Physiol; 1980 Jan; 238(1):H87-92. PubMed ID: 7356037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carbocyclic thromboxane A2: aggrevation of myocardial ischemia by a new synthetic thromboxane A2 analog.
    Smith EF; Lefer AM; Aharony D; Smith JB; Magolda RL; Claremon D; Nicolaou KC
    Prostaglandins; 1981 Mar; 21(3):443-56. PubMed ID: 7232768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of thromboxane inhibition on the severity of myocardial ischemia in cats.
    Smith EF; Lefer AM; Smith JB
    Can J Physiol Pharmacol; 1980 Mar; 58(3):294-300. PubMed ID: 7378931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological properties of pinane-thromboxane A2, a selective inhibitor of coronary artery constriction, platelet aggregation, and thromboxane formation.
    Nicolaou KC; Magolda RL; Smith JB; Aharony D; Smith EF; Lefer AM
    Proc Natl Acad Sci U S A; 1979 Jun; 76(6):2566-70. PubMed ID: 288046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of ischemic cat myocardium by CGS-13080, a selective potent thromboxane A2 synthesis inhibitor.
    Burke SE; DiCola G; Lefer AM
    J Cardiovasc Pharmacol; 1983; 5(5):842-7. PubMed ID: 6195474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-ischemic actions of a new thromboxane receptor antagonist during acute myocardial ischemia in cats.
    Brezinski ME; Yanagisawa A; Darius H; Lefer AM
    Am Heart J; 1985 Dec; 110(6):1161-7. PubMed ID: 3000159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of a new carbacyclin derivative, ZK 36 374, in acute myocardial ischemia.
    Schrör K; Ohlendorf R; Darius H
    J Pharmacol Exp Ther; 1981 Oct; 219(1):243-9. PubMed ID: 6169823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial actions of the thromboxane receptor antagonist, AH-23,848, in acute myocardial ischemia.
    Brezinski ME; Osborne JA; Yanagisawa A; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 Nov; 9(11):703-9. PubMed ID: 2966270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of a novel thromboxane analog in lethal traumatic shock.
    Lefer AM; Araki H; Smith JB; Nicolaou KC; Magolda RL
    Prostaglandins Med; 1979 Sep; 3(3):139-46. PubMed ID: 552102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-thromboxane A2 actions of pinane thromboxane A2 derivatives.
    Roth DM; Lefer AM; Smith JB; Nicolaou KC
    Prostaglandins Leukot Med; 1982 Nov; 9(5):503-9. PubMed ID: 6960376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of flurbiprofen on myocardial cell damage in acute myocardial ischemia.
    Smith EF; Carrow BA; Lefer AM
    Res Commun Chem Pathol Pharmacol; 1980 Jun; 28(3):413-33. PubMed ID: 7403657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preservation of ischemic myocardial tissue with an antagonist of vasoconstrictor eicosanoids.
    Lefer AM; Burke SE; Lepran I
    Can J Physiol Pharmacol; 1984 Dec; 62(12):1487-91. PubMed ID: 6241500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2.
    Lefer AM; Smith EF; Araki H; Smith JB; Aharony D; Claremon DA; Magolda RL; Nicolaou KC
    Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1706-10. PubMed ID: 6929517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of trapidil on thromboxane A2-induced aggregation of platelets, ischemic changes in heart and biosynthesis of thromboxane A2.
    Ohnishi H; Kosuzume H; Hayashi Y; Yamaguchi K; Suzuki Y; Itoh R
    Prostaglandins Med; 1981 Mar; 6(3):269-81. PubMed ID: 6894333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboxane synthetase inhibitors differentially antagonize thromboxane receptors in vascular smooth muscle.
    Smith EF; Lefer AM; Smith JB; Nicolaou KC
    Naunyn Schmiedebergs Arch Pharmacol; 1981 Dec; 318(2):130-4. PubMed ID: 6276789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of the specific thromboxane receptor antagonist, BM-13505, in reperfusion injury following acute myocardial ischemia in cats.
    Bhat AM; Sacks H; Osborne JA; Lefer AM
    Am Heart J; 1989 Apr; 117(4):799-803. PubMed ID: 2929397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antagonism of platelet aggregation by 13-azaprostanoic acid in acute myocardial ischemia and sudden death.
    Burke SE; Roth DM; Lefer AM
    Thromb Res; 1983 Mar; 29(5):473-88. PubMed ID: 6857596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of myocardial salvage by tissue type plasminogen activator in combination with a thromboxane synthetase inhibitor in ischemic cat myocardium.
    Lefer AM; Mentley R; Sun JZ
    Circ Res; 1988 Sep; 63(3):621-7. PubMed ID: 3136950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective actions of a selective thromboxane synthetase inhibitor in acute myocardial ischemia.
    Burke SE; Lefer DJ; Lefer AM
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):76-84. PubMed ID: 6686001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of thromboxane A2 injection on the rabbit coronary artery. I. Physiologic effects in healthy animals.
    Sasagawa S; Moriya K; Sugaya Y; Mitani J; Yajima M
    Exp Mol Pathol; 1982 Aug; 37(1):111-7. PubMed ID: 7117494
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.